Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Crystal Formulation Services, a subsidiary of Crystal Pharmatech, was recently granted the "Drug Manufacturing License" (C Certificate) by the Jiangsu Medical Products Administration, a branch of the Chinese National Medical Products Administration (...
read more
DDL, Inc. has implemented a GMP compliant quality system at its Irvine, CA laboratory to govern its container closure integrity testing (CCIT) division.
read more
Paradigm Clinical Research opened a clinical research site in Littleton, Colorado, their fourth location. The new site location complements the company's long-standing site in Wheat Ridge, Colorado.
read more
Asahi Kasei Bioprocess America and GeminiBio entered into a strategic partnership to advance the application of inline buffer formulation (IBF) in the biopharmaceutical industry.
read more
Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions (Upperton) has expanded its oral dosage form capabilities at its newly built headquarters in Nottingham, UK.
read more
Framework Solutions announced the appointment of Russ Belden as Head of Commercial Solutions, effective April 26th, 2023.
read more
Elligo Health Research has opened its new clinical research center in Austin, Texas. This new center, which was previously located at Elligo’s Austin headquarters, is three times larger than the original space — increasing capabilities and capacity ...
read more
Exothera has partnered with Quantoom Biosciences to gain access to Quantoom’s Nfinity technology, a continuous production platform for RNA.
read more
AeroSafe Global announced the launch of its Patient and Provider Services which comprise Control Tower and Personalized Engagement, enable proactive monitoring of the delivery process with the personalized patient and provider engagement to minimize ...
read more
Aldevron will expand its mRNA production capabilities to include lipid nanoparticle(LNP) encapsulation and aseptic fill-finish capabilities enabling mRNA cGMP manufacturing services from Master Cell Bank through to Drug Product.
read more
MicrofluidX, a UK-based provider of bioreactors for cell biology research and cell therapy manufacturing, announced a joint research project with Immatics, a developer of T cell receptor (TCR)-based immunotherapies, to combine Immatics’ manufacturing...
read more
Exothera has partnered with Quantoom Biosciences to gain access to Quantoom’s Nfinity technology, a continuous production platform for RNA.
read more
With an organic capex investment in Two Phases, the strategic expansion provides biotech and pharma customers with a fully-integrated API to Drug Product service offering organized under a new Oligonucleotides Platform.
read more
Syneos Health® announced the appointment of Michael Bonello as Chief Financial Officer, effective July 1, 2023. Stanford (Ben) Rudnick will continue to serve as Interim Chief Financial Officer until that time.
read more
Clearmind Medicine Inc. announced an agreement with IMP Clinical Supply Services.
IMP will be responsible for the global clinical supply chain of Clearmind’s proprietary drug candidate CMND-100 from manufacture to the various clinical sites.
read more